| Date | Title | Description |
| 15.09.2026 | Startup Funding News Today, September 15, 2026: EUCLYD, Yincheng Intelligence, Nutshell Therapeutics, Yoom & More | The most important signal from startup funding this morning is not another frontier-model megadeal. Capital is moving into the systems underneath AI and into the physical industries where AI has to prove it can improve economics outside a c... |
| 02.06.2022 | Watchmaker Genomics Raises $40M to Expand Clinical Sequencing Product Offerings | What You Should Know:
– Watchmaker Genomics, a life sciences company specializing in the development of high-stringency applications focused on the reading, writing, and editing of DNA and RNA raises $40M in an oversubscribed Series A, brin... |
| 25.06.2020 | Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies | Polares Medical SA, a clinical stage medical technology company based in Lausanne announced today the closing of a $40 million financing led by Longitude Capital (Menlo Park) with the participation of Decheng Capital (Menlo Park / Shanghai)... |
| 25.06.2020 | Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies | |
| 18.07.2018 | Polares Medical closes a $25M financing round | |
| 15.11.2016 | Term Sheet — Tuesday, November 15 | ET CETERA
• The Capital of Fintech: There’s apparently a fight, or battle, or race on between cities to become the Capital of FinTech. Hubs, scenes, ecosystems “capitals,” and various spins on the phrase Silicon Valley are overrated.
Paid C... |
| 02.07.2014 | GeneWeave BioSciences Raises $12M | GeneWeave BioSciences, a Los Gatos, Calif.-based clinical diagnostics company addressing multi-drug-resistant organisms (MDRO), raised $12m in funding.
The round was led by Decheng Capital with participation from existing investors Claremon... |
| 28.02.2012 | GeneWeave Biosciences Raises $12M in Series A Venture Capital Funding | GeneWeave Biosciences, a San Jose, CA-based developer of a platform for the rapid detection of infectious disease, has raised $12m in a Series A venture capital funding.
The round was led by Decheng Capital, with participation from existing... |